Drugs / Tri-Luma
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | TRI-LUMA | — | 2002-01-18 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01778179 Comparator | Apr 2011 → Dec 2012 | lentigo | Hexsel Dermatology Clinic | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tri-Luma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01778179 ↗ |
| Route | Topical | “Tri-Luma® cream will be applied again (group 1)” NCT01778179 ↗ |